Pretreatment with glucose–insulin–potassium improves ventricular performances after coronary artery bypass surgery: a randomized controlled trial

@article{Licker2019PretreatmentWG,
  title={Pretreatment with glucose–insulin–potassium improves ventricular performances after coronary artery bypass surgery: a randomized controlled trial},
  author={Marc Licker and Thomas Reynaud and Najia Garofano and Tornike Jemal Sologashvili and John Diaper and Christoph Ellenberger},
  journal={Journal of Clinical Monitoring and Computing},
  year={2019},
  pages={1-12}
}
Heart failure is the main cause of poor outcome following open heart surgery and experimental studies have demonstrated that glucose–insulin–potassium (GIK) infusion exerts cardioprotective effects by reducing myocardial ischemia–reperfusion injuries. This randomized controlled trial was designed to assess the effects of GIK on left ventricular function in moderate-to-high risk patients undergoing on-pump isolated coronary artery bypass surgery (CABGS), or combined with aortic valve replacement… CONTINUE READING
BETA